CRYSVITA 20 mg solution for injection
- Licence status
- Active substances
- Recombinant human igg1 monoclonal antibody to fibroblast growth factor 23
- Dosage Form
- Solution for injection
- Licence number
- EU/1/17/1262/002
- Licence holder
- Kyowa Kirin Holdings B.V.
Product documents
Licence information
- ATC code
- M05BX Other drugs affecting bone structure and mineralization, M05BX05 burosumab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 19/02/2018